BioSpace News Archive

On Monday, LogicBio Therapeutics unveiled clinical trial results demonstrating the first-ever in vivo, nuclease-free genome editing in little humans.

June really broke out in 2012 when he saved the life of Emily Whitehead, a child suffering from relapsed acute lymphoblastic leukemia (ALL), with CD19 CAR-T.

Calithera Biosciences is expanding its oncology portfolio with the addition of two clinical-stage compounds from Takeda Pharmaceuticals.

Crinetics Pharmaceuticals, along with 5AM Ventures and Frazier Healthcare Partners, announced that it was spinning out a new company, Radionetics Oncology.

Applied Genetic Technologies today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the Dry AMD Therapeutic Development Summit being held virtually October 19 – 21, 2021.

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), today announced the appointment of Matthias Alder as Chief Operating Officer to advance the Company’s strategic and operational objectives, including the establishment of additional industry partnerships and the transition of the Company’s lead program in Gaucher and Parkinson’s Disease into clinical trials, which is expected to occur in 2022.

Akoya Biosciences, Inc. today announced that it will release financial results for the third quarter of 2021 after the market close on Monday, November 8th , 2021.

CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Mason W. Freeman, M.D., as Executive Vice President, Clinical Development responsible for leading all clinical development at CinCor.

Avadel Pharmaceuticals plc today announced new data from the completed pivotal Phase 3 REST-ON clinical trial of FT218, also known as ON-SXB.

Ring Therapeutics today announced preclinical data highlighting its Anellogy™ platform.